Back to Agenda
Breakout Session 3A: Counterfeit
Session Chair(s)
Ruth Lee
Director, Enforcement Branch
Health Sciences Authority, Singapore
Raymond H. Velez
Regional Manager, South Asia Pacific, Global Product Protection
Eli Lilly (Singapore) Pte., Ltd., Singapore
Counterfeit medical products pose a significant danger to public health in both developing and developed countries. The global nature of manufacturing and trade in medical products makes it crucial that all countries work together in a concerted effort to reduce the growing market for counterfeit medical products. In this session, three key speakers representing WHO, INTERPOL and Pharmaceutical Security Institute (PSI) will highlight their respective roles and responsibilities, as well as their efforts in combating this global problem of counterfeit medical products. Sensitivities surrounding this topic and the challenge of achieving effective collaborations among all stakeholders to achieve the common goal of protecting public health and safety will also be discussed.
Speaker(s)
INTERPOL's Successful Model in Combating Cyber Pharmaceutical Crime
Cecilia Fant
INTERPOL, France
Superintendent
PSI - A Unique Ally and Key to Effective Partnerships
Thomas T. Kubic
Pharmaceutical Security Institute, United States
President & CEO
Counterfeit and Supply Chain
Mohd Hatta Bin Ahmad
Ministry of Health Malaysia, Malaysia
Director of Pharmacy Enforcement Division
Have an account?